Tag: next generation mRNA-based vaccines
GSK, CureVac team up to develop and manufacture vaccine against COVID-19 mutants
UK-based GlaxoSmithKline announced today that it has partnered with German pharmaceutical company CureVac to jointly develop next-generation mRNA vaccines for emerging COVID-19 variants.
The €150m...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
